We've tried to summarize the data from some of the stock subreddits here into different categories. The categories are Recent Posts, Due Diligence (DD), Discussions or News. The News here is usually not the news in media but still very relevant information.
| Date | Title | Subreddit | Price |
|---|
| Date | Title | Subreddit | Price |
|---|---|---|---|
| Nov-15-2021 | Impel NeuroPharma, Inc. (IMPL) CEO Adrian Adams on Q3 2021 Results - Earnings Call Transcript | 10.255 | 0.00 |
| Sep-28-2021 | Impel NeuroPharma Announces Trudhesa™ (Dihydroergotamine Mesylate) Nasal Spray is Now Available for Prescription for the Acute Treatment of Migraine | 13.25 | 0.00 |
| Sep-28-2021 | Carepoint Pharmacy Selected by Impel NeuroPharma as a Digital Pharmacy Partner for the Launch of Trudhesa™ (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine | 14.07 | 0.00 |
| Sep-10-2021 | Impel NeuroPharma To Raise $45M Via Equity Offering | 21.13 | 0.00 |
| Sep-10-2021 | Why Impel NeuroPharma Dived by 24% Today | 16.175 | 0.00 |
| Sep-09-2021 | Why Impel NeuroPharma Stock Blasted 27% Higher Thursday | 21.13 | 0.00 |
| Sep-09-2021 | Impel NeuroPharma Announces Pricing of $45.0 Million Public Offering | 21.13 | 0.00 |
| Date | Title | Subreddit | Price |
|---|---|---|---|
| Jan-25-2022 | Even under the current circumstances, IMPL is on the rise. The company will show surprise in its next earnings announcement. They will lead the migraine market | StockMarket | 9.45 |
| Date | Title | Subreddit | Price |
|---|